3 unknown. 3 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 3 | Unknown 3 |
Follow Seroma: new trials by email Literature Review of Seroma trials Research Report on Seroma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| SEroma Reduction pOst MAstectomy "SEROMA Study" Tranexamic Acid 100mg/mL, 20mL topical, Normal Saline Flush, 0.9%, 20mL topical - Seroma Complicating A Procedure, Hematoma Postoperative | Phase 4 | Unknown | Hamilton Health Sciences Corporation | 100 | 2019-10-07 | 2021-02-21 |
| Tranexamic Acid for Bleeding in Breast Surgery Tranexamic Acid, Placebo - Hematoma, Seroma | Phase 4 | Unknown | Ottawa Hospital Research Institute | 800 | 2016-02-01 | 2016-01-12 |
| Does a Single Steroid Injection Reduce the Formation of Postmastectomy Seroma Solu-medrol 125 mg - Breast Neoplasms, Mastectomy | Phase 4 | Unknown | Herlev Hospital | 40 | 2005-12-01 | 2007-09-06 |
Breast Neoplasms (2) · Hematoma (2)
Inflammation (3) · Pathologic Processes (3) · Pathological Conditions, Signs and Symptoms (3) · Breast Diseases (2) · Hemorrhage (2) · Neoplasms (2) · Neoplasms by Site (2) · Skin Diseases (2) · Skin and Connective Tissue Diseases (2)
Tranexamic Acid (2) · Methylprednisolone Hemisuccinate (1)
Hamilton Health Sciences Corporation (1) · Herlev Hospital (1) · Ottawa Hospital Research Institute (1)
Canada (1) · Denmark (1)